Biological Information

Background Information:

JMJD2C (Jumonji domain-containing protein 2C), also known as KDM4C, is a histone demethylase that belongs to the JmjC domain-containing protein family. Like other members of this family, JMJD2C specifically targets di- and tri-methylated lysine residues on histones H3 and H4, and catalyzes their removal, leading to changes in chromatin structure and gene expression. JMJD2C is expressed in a variety of tissues, including the brain, heart, and liver, and is involved in the regulation of various cellular processes, including differentiation, proliferation, and apoptosis.
JMJD2C has been implicated in the development of several types of cancer, including breast, ovarian, and colorectal cancers. It has also been shown to play a role in the regulation of various viral infections, including human papillomavirus (HPV) and hepatitis B virus (HBV). Therefore, JMJD2C has emerged as a potential target for the development of novel therapeutics for cancer and viral infections.

Target Class:

Epigenetic

Family:

Histone Demethylase

Sub Family:

Eraser

Protein Name:

JMJD2C

Protein Aliases:

tudor domain containing 14C

Accession Number:

NM_015061.6

UniProt Number:

Q9H3R0

Gene Name:

KDM4C

Gene ID:

23081

Gene Aliases:

GASC1|KIAA0780|TDRD14C

Target Species:

Human

Usage

Product Type:

Enzymes

Application:

Drug Discovery & Development

Storage Conditions:

1 year at -70°C

Usage disclaimer:

These products may be covered by issued US and/or foreign patents, patent applications and subject to a Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information.

Assay Information

Assay Type:

Enzymatic

Bioassay Data

Trademark Statement:

For Research Use Only